Arca
Skip to content
Tools
Tools

Neurofibromatosis 1

Drug research and approvals for neurofibromatosis 1: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 43 studies of neurofibromatosis 1 are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and the EU has 2 authorised medicines for it.

  • Recruiting worldwide: 43
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 2

Recruiting now

Newest posted first, of 43 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 1

  • SelumetinibDual specificity mitogen-activated protein kinase kinase 1 inhibitor

Phase 2 12 of 16

Phase 1 or earlier 3

How its trials ended

215 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 37 whose ending is known, 35% met their primary endpoint, 11% missed it and 54% stopped early.

  • Completed, result not reported8941%
  • Ongoing6932%
  • Status unknown209%
  • Met its primary endpoint136%
  • Stopped: other or unclear94%
  • Stopped: enrollment or feasibility84%
  • Missed its primary endpoint42%
  • Stopped: sponsor or business decision21%
  • Stopped: lack of efficacy1<1%

Medicines authorised in the EU

Newest first
Jul 17, 2025EzmeklyMirdametinib · orphanMerck Europe B.V.EMA ↗
Jun 17, 2021KoselugoSelumetinib · orphanAstraZeneca ABEMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.